Correction to: Cancer Gene Therapy (2007) 14: 165–173. doi:10.1038/sj.cgt.7700998; published online 29 September 2006
Since the publication of the above paper, the authors have noticed an error in the labelling of Figure 4a. The corrected Figure 4 is shown below.
Non-viral DNA complexes encoding cytosolic SAP injected into B16 melanoma-bearing mice are able to induce an antitumor effect. Subcutaneous B16 tumors with a diameter of 5 mm were injected with 50 μg/animal of pCI (control) or pCI-SAP complexed with lipofectamine (a) or DOTAP (b and c). The effect of single (a and b) or repeated (c) administrations was monitored. The time of injection is indicated by arrows. Results are presented as mean±s.e. of five animals per group. ∧P<0.05 relative to untreated; *P<0.05 relative to control plasmid; ∧∧P<0.01 relative to untreated; **P<0.01 relative to control plasmid.
Additional information
The online version of the original article can be found at 10.1038/sj.cgt.7700998
Rights and permissions
About this article
Cite this article
Zarovni, N., Vago, R., Soldà, T. et al. Erratum: Saporin as a novel suicide gene in anticancer gene therapy. Cancer Gene Ther 14, 521 (2007). https://doi.org/10.1038/sj.cgt.7701046
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7701046
